FDA Panel Rejects Use of MDMA for Treatment of PTSD
An independent group of experts expressed concerns that the data from clinical trials did not outweigh risks for treatment of post-traumatic stress disorder.
HALO NEWSLETTER
Keep reading HALO with a Free Subscription
unlock this story instantly and join members and pros reading HALO daily
-It's
Free